| |
| |
|
| Insider
Information: |
Morrison Scott W |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
27,581 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$434,929 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,581 |
|
|
| Total
Value |
$434,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -17.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Global Blood Therapeutics, Inc. |
GBT |
Director |
2022-10-05 |
0 |
|
0 |
Premium* |
|
|
Audentes Therapeutics, Inc. |
BOLD |
|
|
0 |
|
0 |
Premium* |
|
|
Corvus Pharmaceuticals, Inc. |
CRVS |
|
|
0 |
|
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
26,248 |
2021-10-18 |
0 |
Premium* |
|
|
Tarsus Pharmaceuticals, Inc. |
TARS |
Director |
2023-09-15 |
1,333 |
2023-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2023-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,333 |
1,333 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
|
– • – |
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
26,248 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2022-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,637) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,600 |
6,637 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-10-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,345 |
7,345 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2021-09-09 |
4 |
S |
$30.21 |
$145,003 |
D/D |
(4,800) |
3,037 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2021-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,037 |
7,837 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2020-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,800 |
4,800 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
